Delivery Order SPE2DB24D8001-SPE2DB25FKZFX
Award Date
2/20/25
Potential Completion Date
3/13/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,611.72 firm fixed-price delivery order is for the provision of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is associated with Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of PROQUAD vials. The $2,580.94 contract has an ultimate completion date of January 17, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA's ECAT Generation V Program, which...
The federal government awarded a firm-fixed-price delivery order contract worth $3,511.46 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of PROQUAD VIALS. This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical division, a component of the Department of Defense, and has an ultimate completion date of March 24, 2023. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment...
The federal contract award SPE2DX15D8002|SPE2DX24F2TS8, valued at $2,818.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the provision of PROQUAD VIALS, a pharmaceutical product. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,231.24 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, with the DLA as part of the ECAT Generation V...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is valued at $1,755.73 and covers the delivery of PROQUAD VIALS, a type of pharmaceutical product, to support military medical operations. The contract is not set aside and is awarded under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) with the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of PROQUAD VIALS. The fixed-price contract has a ceiling value of $5,162.20 and a performance period through August 22, 2022. Dakota Drug, Inc. has a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the ECAT Generation V Program to provide a range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $3,231.24, is for the delivery of PROQUAD VIALS, a type of medical supply. The contract has an ultimate completion date of September 1, 2022. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA...
This federal contract award, identified as SPE2DX15D8001|SPE2DX22FBRHF, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,196.71 firm-fixed-price delivery order is for the provision of PROQUAD VIALS, a pharmaceutical product, with an ultimate completion date of October 3, 2022. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, as part of the...
This federal contract award SPE2DX15D8003|SPE2DX23F7C4W, valued at $8,454.51, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the procurement of PROQUAD VIALS, a type of medical supply. This award is not associated with a set-aside program and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at $999,999,999.00 under the DLA Troop Support...